Hôpital Necker

Paris 75743

2 studies enrolling now · 17 studies all time

What they study most

Acute Myeloid Leukemia (AML), Adult T Cell Leukemia/Lymphoma, Arthritis, Psoriatic, CPSS (Congenital Portosystemic Shunt), Colitis, Ulcerative, Congenital Portosystemic Shunt, Constipation - Functional, Crohn Disease, Delayed Graft Function, Higher-Risk Myelodysplastic Syndrome (HR-MDS), Indolent Systemic Mastocytosis, Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Studies at this site

• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now
• A Long-term Extension Study of Ustekinumab in Pediatric Participants — Running, not enrolling
• Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow — Running, not enrolling
• A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day — Running, not enrolling
• International Registry of Congenital Portosystemic Shunt (IRCPSS) — Enrolling by invitation
• A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease — Completed
• Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications — Completed
• Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children — Completed
• Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy — Completed
• Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients — Completed
• Lubiprostone in Children With Functional Constipation — Completed
• QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant — Completed
• Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis — Completed
• A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma — Stopped early
• I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation — Completed